Forte Biosciences, Inc. (FBRX): Price and Financial Metrics


Forte Biosciences, Inc. (FBRX): $1.29

0.09 (+7.50%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FBRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

FBRX Stock Price Chart Interactive Chart >

Price chart for FBRX

FBRX Price/Volume Stats

Current price $1.29 52-week high $7.26
Prev. close $1.20 52-week low $1.03
Day low $1.18 Volume 102,900
Day high $1.30 Avg. volume 191,023
50-day MA $1.33 Dividend yield N/A
200-day MA $2.28 Market Cap 19.04M

Forte Biosciences, Inc. (FBRX) Company Bio


Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.


FBRX Latest News Stream


Event/Time News Detail
Loading, please wait...

FBRX Latest Social Stream


Loading social stream, please wait...

View Full FBRX Social Stream

Latest FBRX News From Around the Web

Below are the latest news stories about Forte Biosciences Inc that investors may wish to consider to help them evaluate FBRX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | February 8, 2022

Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12%

During the last session, Forte Biosciences Inc. (NASDAQ:FBRX)’s traded shares were 3.02 million, with the beta value of the company hitting 0.67. At the end of the trading day, the stock’s price was $2.14, reflecting an intraday gain of 5.94% or $0.12. The 52-week high for the FBRX share is $43.57, that puts it down … Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12% Read More »

Marketing Sentinel | December 17, 2021

Here's Why We're Watching Forte Biosciences' (NASDAQ:FBRX) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | December 15, 2021

Forte Biosciences, Inc. (NASDAQ:FBRX) Expected to Post Earnings of -$0.38 Per Share

Wall Street analysts predict that Forte Biosciences, Inc. (NASDAQ:FBRX) will post earnings of ($0.38) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Forte Biosciences earnings. The business is scheduled to announce its next quarterly earnings results on Wednesday, March 23rd. According to Zacks, analysts expect that Forte Biosciences will []

Transcript Daily | December 8, 2021

Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest?

Forte Biosciences Inc. (NASDAQ:FBRX) concluded the trading at $2.24 on Friday, December 03 with a fall of -7.44% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.42 with its price kept floating in the range of $2.22 and $2.42 on the Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest? Read More »

Stocks Register | December 4, 2021

Read More 'FBRX' Stories Here

FBRX Price Returns

1-mo 4.88%
3-mo -2.27%
6-mo -50.95%
1-year -78.22%
3-year -87.77%
5-year -96.84%
YTD -39.72%
2021 -64.73%
2020 355.24%
2019 -93.51%
2018 -19.90%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4389 seconds.